Russell Investments Group Ltd. lessened its stake in Simulations Plus, Inc. (NASDAQ:SLP - Free Report) by 16.6% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 179,231 shares of the technology company's stock after selling 35,753 shares during the quarter. Russell Investments Group Ltd. owned approximately 0.89% of Simulations Plus worth $4,999,000 at the end of the most recent reporting period.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. State Street Corp increased its holdings in shares of Simulations Plus by 4.7% in the third quarter. State Street Corp now owns 640,303 shares of the technology company's stock worth $20,503,000 after purchasing an additional 28,953 shares during the last quarter. Barclays PLC raised its position in shares of Simulations Plus by 390.6% during the 3rd quarter. Barclays PLC now owns 28,473 shares of the technology company's stock valued at $911,000 after buying an additional 22,669 shares in the last quarter. Geode Capital Management LLC lifted its holdings in shares of Simulations Plus by 4.4% in the 3rd quarter. Geode Capital Management LLC now owns 448,618 shares of the technology company's stock valued at $14,367,000 after acquiring an additional 18,924 shares during the last quarter. Franklin Resources Inc. grew its position in Simulations Plus by 7.6% in the third quarter. Franklin Resources Inc. now owns 10,797 shares of the technology company's stock worth $342,000 after acquiring an additional 766 shares in the last quarter. Finally, Principal Financial Group Inc. lifted its stake in shares of Simulations Plus by 2.6% in the 3rd quarter. Principal Financial Group Inc. now owns 87,273 shares of the technology company's stock valued at $2,794,000 after purchasing an additional 2,226 shares during the last quarter. Institutional investors own 78.08% of the company's stock.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on SLP shares. StockNews.com downgraded Simulations Plus from a "hold" rating to a "sell" rating in a research report on Monday, April 14th. KeyCorp increased their target price on shares of Simulations Plus from $32.00 to $40.00 and gave the company an "overweight" rating in a research note on Wednesday. Finally, William Blair restated an "outperform" rating on shares of Simulations Plus in a report on Wednesday, January 8th. One analyst has rated the stock with a sell rating, one has assigned a hold rating, five have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $50.00.
Read Our Latest Analysis on SLP
Simulations Plus Trading Up 1.5 %
Shares of SLP traded up $0.49 during trading hours on Friday, reaching $32.69. 336,728 shares of the company traded hands, compared to its average volume of 193,468. The firm has a market cap of $657.43 million, a price-to-earnings ratio of 81.73 and a beta of 1.13. Simulations Plus, Inc. has a 12-month low of $23.01 and a 12-month high of $51.22. The stock's fifty day moving average price is $28.55 and its 200 day moving average price is $30.09.
Simulations Plus (NASDAQ:SLP - Get Free Report) last announced its quarterly earnings results on Thursday, April 3rd. The technology company reported $0.31 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.06. The firm had revenue of $22.43 million during the quarter, compared to analyst estimates of $21.93 million. Simulations Plus had a return on equity of 6.84% and a net margin of 10.97%. Simulations Plus's quarterly revenue was up 22.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.20 earnings per share. On average, research analysts forecast that Simulations Plus, Inc. will post 1.09 earnings per share for the current year.
Insider Transactions at Simulations Plus
In other news, Director Walter S. Woltosz sold 20,000 shares of the stock in a transaction that occurred on Monday, February 3rd. The shares were sold at an average price of $33.91, for a total transaction of $678,200.00. Following the transaction, the director now directly owns 3,402,584 shares in the company, valued at approximately $115,381,623.44. This trade represents a 0.58 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 19.40% of the company's stock.
Simulations Plus Profile
(
Free Report)
Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.
Featured Articles
Before you consider Simulations Plus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Simulations Plus wasn't on the list.
While Simulations Plus currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
